ATE483470T1 - Verfahren zur expansion tumorreaktiver t- lymphozyten zur immuntherapie von patienten mit krebs - Google Patents

Verfahren zur expansion tumorreaktiver t- lymphozyten zur immuntherapie von patienten mit krebs

Info

Publication number
ATE483470T1
ATE483470T1 AT06841050T AT06841050T ATE483470T1 AT E483470 T1 ATE483470 T1 AT E483470T1 AT 06841050 T AT06841050 T AT 06841050T AT 06841050 T AT06841050 T AT 06841050T AT E483470 T1 ATE483470 T1 AT E483470T1
Authority
AT
Austria
Prior art keywords
lymphocytes
reactive
tumour
helper
phase
Prior art date
Application number
AT06841050T
Other languages
English (en)
Inventor
Ola Winqvist
Magnus Thoern
Original Assignee
Sentoclone Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentoclone Ab filed Critical Sentoclone Ab
Priority claimed from PCT/EP2006/012304 external-priority patent/WO2007071388A1/en
Application granted granted Critical
Publication of ATE483470T1 publication Critical patent/ATE483470T1/de

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06841050T 2005-12-21 2006-12-20 Verfahren zur expansion tumorreaktiver t- lymphozyten zur immuntherapie von patienten mit krebs ATE483470T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75282805P 2005-12-21 2005-12-21
DKPA200501810 2005-12-21
PCT/EP2006/012304 WO2007071388A1 (en) 2005-12-21 2006-12-20 Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer

Publications (1)

Publication Number Publication Date
ATE483470T1 true ATE483470T1 (de) 2010-10-15

Family

ID=36763835

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841050T ATE483470T1 (de) 2005-12-21 2006-12-20 Verfahren zur expansion tumorreaktiver t- lymphozyten zur immuntherapie von patienten mit krebs

Country Status (5)

Country Link
CN (1) CN101346463B (de)
AT (1) ATE483470T1 (de)
BR (1) BRPI0620187A2 (de)
DE (1) DE602006017435D1 (de)
NZ (1) NZ569105A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6588465B2 (ja) * 2014-01-03 2019-10-09 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 修飾ナチュラルキラー細胞、その組成物および用途
WO2016044811A1 (en) * 2014-09-19 2016-03-24 City Of Hope COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13Rα2
GB201519340D0 (en) * 2015-11-02 2015-12-16 Cambridge Entpr Ltd Methods of T-lymphocyte expansion
CN105586312A (zh) * 2016-02-29 2016-05-18 时宏珍 Hla-a0201限制性抗muc-1抗原特异性ctl的制备方法
JP7038100B2 (ja) * 2016-07-21 2022-03-17 バークレー ライツ，インコーポレイテッド マイクロ流体デバイスでのｔリンパ球の選別
CN106754703B (zh) * 2016-12-26 2018-03-16 浙江丹晖生物科技有限公司 一种til细胞体外扩增培养基组合和培养方法
SG11201907102XA (en) * 2017-02-07 2019-08-27 Univ Saitama Medical Immunological biomarker for predicting clinical effect of cancer immunotherapy

Also Published As

Publication number Publication date
DE602006017435D1 (de) 2010-11-18
CN101346463A (zh) 2009-01-14
BRPI0620187A2 (pt) 2011-11-01
NZ569105A (en) 2011-07-29
CN101346463B (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
ATE483470T1 (de) Verfahren zur expansion tumorreaktiver t- lymphozyten zur immuntherapie von patienten mit krebs
Amatore et al. Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy
Gao et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells
Bachanova et al. NK cells in therapy of cancer
Bracci et al. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
Putnam et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation
Smith et al. Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses
PE20210256A1 (es) Anticuerpos anti-lag3
Tang et al. Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
MXPA05011755A (es) Composiciones y metodos para inmunoterapia especifica de tumor wilms 1.
MX2019011570A (es) Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
MX2017008658A (es) Inmunoterapia antitumoral combinada.
WO2005100399A3 (en) Dr5 antibodies and uses thereof
Yee Adoptive therapy using antigen-specific T-cell clones
KR20090126329A (ko) 인간 혈액 유래의 ｃｄ4＋ｃｄ25＋ 조절성 ｔ 세포
EP3467101A3 (de) Immuntherapie von hirntumor mithilfe gentechnisch manipulierter gd2-spezifischer t-zellen
Felices et al. Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation
MX2023001962A (es) Composiciones anti-cd28.
AU9660801A (en) Compositions and methods for wt1 specific immunotherapy
TW200531679A (en) Methods of modulating cytokine activity; related reagents
US20170298322A1 (en) Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseases
MX2008008278A (es) Agonistas sinteticos novedosos de receptores tipo toll que contienen modificaciones de dinucleotido cg.
NZ529404A (en) A cell therapy method for the treatment of tumours
DE602005016887D1 (de) Poliersystem mit hochverzweigtem polymer
Facchetti et al. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties